Acute Kidney Injury = Higher Mortality

Medical News: Acute Kidney Injury Linked to Mortality – in Nephrology, General Nephrology from MedPage Today

Lafrance and Miller looked at VA data involving 864,933 U.S. veterans (4.9% female) who survived at least 90 days after a hospital discharge. Of those, 82,711 had acute kidney injury that did not require dialysis.

Through a mean follow-up of 2.34 years, the rate of death was higher in patients with acute kidney injury — 29.8% versus 16.1%.

After adjustment for demographics, comorbidities, medication use, primary diagnosis of admission, length of stay, mechanical ventilation, and postdischarge kidney function (estimated glomerular filtration rate), patients with acute kidney injury were 41% more likely to die during follow-up (HR 1.41, 95% CI 1.39 to 1.43).

The mortality risk increased significantly with greater severity of acute kidney injury (P<0.001 for trend), reaching a hazard ratio of 1.59 (95% CI 1.54 to 1.65) for those with stage III injury.

The risk of dying during follow-up was reduced, but still elevated, in patients with lower baseline kidney function, older patients, and those with diabetes.

Even among patients whose kidney function declined by 10% or less from the baseline assessment — who were considered to have recovered or to have maintained function — acute kidney injury was still associated with significantly higher mortality (HR 1.47, 95% CI 1.43 to 1.51).

Agranulocytosis? Consider Cocaine

Medical News: CDC Confirms Agranulocytosis Cases from Adulterated Cocaine – in Psychiatry, Addictions from MedPage Today

The CDC has confirmed reports from other government agencies that cocaine users are at risk for agranulocytosis because of contamination with the veterinary drug levamisole.

Watch Your Diabetic Medications

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database — Tzoulaki et al. 339: b4731 — BMJ

Conclusions Our findings suggest a relatively unfavourable risk profile of sulphonylureas compared with metformin for all outcomes examined. Pioglitazone was associated with reduced all cause mortality compared with metformin. Pioglitazone also had a favourable risk profile compared with rosiglitazone; although this requires replication in other studies, it may have implications for prescribing within this class of drugs.

CRP as Risk Factor for CHD

C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force — Ann Intern Med

Conclusion: Strong evidence indicates that CRP is associated with CHD events. Moderate, consistent evidence suggests that adding CRP to risk prediction models among initially intermediate-risk persons improves risk stratification. However, sufficient evidence that reducing CRP levels prevents CHD events is lacking.